Primates at Tulane key to finding coronavirus vaccine | Animal studies show remdesivir might work against coronavirus | Monkeys may be good models of early-stage Alzheimer's
February 26, 2020
FBR SmartBrief
Top Stories
Primates at Tulane key to finding coronavirus vaccine
(Hector Retamal/Getty Images)
Tulane National Primate Research Center is equipped to handle research on infectious agents like the coronavirus circulating now, and director Jay Rappaport expects to receive samples and begin testing how the virus affects rhesus and African green monkeys, whose responses to coronaviruses are similar to human responses. Scientists expect to begin testing vaccine candidates in four to six months, and findings will be shared with other centers to minimize animal testing.
Full Story: The Times-Picayune | The New Orleans Advocate (2/20) 
LinkedIn Twitter Facebook Email
World Health Organization assistant director-general Bruce Aylward says remdesivir is being tested in humans for treatment of the emerging coronavirus, after the drug demonstrated promise against two related coronaviruses in animal studies. The drug is one of a number of compounds being explored for treatment of COVID-19, the infection caused by the virus, and other companies are working on vaccines to prevent infection.
Full Story: CNN (2/25) 
LinkedIn Twitter Facebook Email
Research Breakthroughs
Scientists at the California National Primate Research Center have developed an adult rhesus monkey model of early-stage Alzheimer's disease that could shed light on how the debilitating disease begins in people. Monkeys injected with soluble amyloid-beta protein fragments had more activated microglia cells, which can damage neurons, than control monkeys, and biomarkers in injected monkeys' cerebrospinal fluid were consistent with very early Alzheimer's in people, researchers reported in Proceedings of the National Academy of Sciences.
Full Story: National Institutes of Health/National Institute on Aging (2/20) 
LinkedIn Twitter Facebook Email
L-serine injections reduced aggregated misfolded proteins and activated microglia in the brains and spinal cords of vervet monkey models of amyotrophic lateral sclerosis, researchers reported in the Journal of Neuropathology & Experimental Neurology, and the amino acid is now being tested in clinical trials. Meanwhile, the vervet model "will be an important new tool in the quest for new drugs to treat ALS," said study coauthor Walter Bradley, an ALS expert.
Full Story: Drug Target Review (U.K.) (2/24) 
LinkedIn Twitter Facebook Email
Heart valve tested in sheep could prevent repeated surgeries in kids
An expandable artificial heart valve tested extensively in sheep could spare children with congenital heart defects from repeated open heart surgeries to replace the valve as they grow, according to a study in Science Translational Medicine. The valve encouraged good blood flow, and no clots formed even in sheep not given anticoagulants that are typically prescribed for patients with artificial heart valves.
Full Story: HealthDay News (2/19) 
LinkedIn Twitter Facebook Email
Scientists at the Massachusetts Institute of Technology used machine learning to identify a structurally distinct antibiotic molecule called halicin that killed Clostridium difficile bacteria when tested in mice. The molecule was listed in a database as a potential treatment for diabetes, and the researchers reported in Cell that they identified eight additional antimicrobial compounds whose structures are significantly different from known antibiotics.
Full Story: STAT (tiered subscription model) (2/20) 
LinkedIn Twitter Facebook Email
Animal Health
3 canine studies seeking glioblastoma cure
Glioblastoma is linked to certain genetic syndromes, but it also occurs in people with no family history of cancer and in some dog breeds, which may be central to finding a cure. A study at Johns Hopkins University involves delivering a radioactive isotope directly into canine glioblastoma and another is using heat and radiation to destroy cancer cells, while researchers at Virginia-Maryland College of Veterinary Medicine are injecting dogs' brain tumors with cytotoxins, and the results of all the studies could translate to human glioblastoma.
Full Story: WJZ-TV (Baltimore) (2/24) 
LinkedIn Twitter Facebook Email
Policy News
An NIH workshop on improving the rigor and reproducibility of monkey studies emphasized the importance and value of research on nonhuman primates, improving animal welfare, and optimizing study design to minimize the number of monkeys needed while generating the most accurate results. The workshop was "an excellent and robust discussion around fostering rigorous research in nonhuman primates," said FBR President Matthew R. Bailey.
Full Story: Science (tiered subscription model) (2/20) 
LinkedIn Twitter Facebook Email
FBR News
Enter FBR's 'Love Animals? Support Animal Research' photo contest
FBR is accepting entries for its LASAR photo contest until Saturday, Feb. 29. Send a picture of you and your furry friend - cat, dog, boa constrictor, or other - to for your chance to win up to $250! For examples of contest submissions and to learn more, please visit our website.
LinkedIn Twitter Facebook Email
Donate to FBR
For 38 years, FBR has advanced biomedical research for the sake of both human and animal health. We can't do our job without your support. Please give what you can. Together we will continue to make a difference.
LinkedIn Twitter Facebook Email
Editor's Note
Updates to Privacy Policy
We want to make sure you are aware of changes to the SmartBrief Privacy Policy, effective Jan. 1, 2020. You can find our updated Privacy Policy here. Some key updates include:
  • New privacy features for Californians' consumer privacy rights under the California Consumer Privacy Act of 2018.
  • Additional information regarding our use of advertising networks and advertising tags.
LinkedIn Twitter Facebook Email
I don't have a feeling of inferiority. Never had. I'm as good as anybody, but no better.
Katherine Johnson,
mathematician, NASA scientist, Presidential Medal of Freedom recipient
February is Black History Month
LinkedIn Twitter Facebook Email
About FBR  |    Donate
About FBR
The Foundation for Biomedical Research (FBR) is the nation’s oldest and largest non-profit dedicated to improving human and animal health by promoting public understanding and support for biomedical research. Our mission is to educate people about the essential role animal research plays in the quest for medical advancements, treatments and cures for both people and animals.
SmartBrief publishes more than 200 free industry newsletters - Browse our portfolio
Sign Up  |    Update Profile  |    Advertise with SmartBrief
Unsubscribe  |    Privacy policy
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004